Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Rowe

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|August 22, 2023
Prediction of outcomes in patients with acute variceal bleedingIan A Rowe
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver diseaseIan A Rowe
Journal of Hepatology|November 10, 2015
Capitalising on improved rates of diagnosis of early hepatocellular carcinomaIan A Rowe, Morris Sherman
Clinical Medicine (London, England)|April 28, 2018
Surveillance for hepatocellular cancerAnna Roskilly, Ian A Rowe
Journal of Hepatology|April 14, 2022
Taking a risk-based approach to testing for liver disease in primary care, a step in the right directionIan A Rowe, Gennaro D'Amico
Hepatology (Baltimore, Md.)|January 19, 2017
What is the benefit of early follow-up after hospitalization for patients with cirrhosis?Robert Driver, Ian A Rowe
Lancet (London, England)|November 30, 2018
Questions in the design of ANSWERIan A Rowe, Richard Parker
Gastroenterology|December 3, 2014
Liver biopsy for the selection of patients with nonalcoholic steatohepatitis for clinical trialsIan A Rowe, Richard Parker
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2021
The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply ExplainedIan A Rowe, Richard Parker
Nature Reviews. Gastroenterology & Hepatology|June 15, 2019
The diagnosis of nonalcoholic fatty liver disease should carry important prognostic informationIan A Rowe, Richard Parker
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|August 22, 2023
Prediction of outcomes in patients with acute variceal bleedingIan A Rowe
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver diseaseIan A Rowe
Journal of Hepatology|November 10, 2015
Capitalising on improved rates of diagnosis of early hepatocellular carcinomaIan A Rowe, Morris Sherman
Clinical Medicine (London, England)|April 28, 2018
Surveillance for hepatocellular cancerAnna Roskilly, Ian A Rowe
Journal of Hepatology|April 14, 2022
Taking a risk-based approach to testing for liver disease in primary care, a step in the right directionIan A Rowe, Gennaro D'Amico
Hepatology (Baltimore, Md.)|January 19, 2017
What is the benefit of early follow-up after hospitalization for patients with cirrhosis?Robert Driver, Ian A Rowe
Lancet (London, England)|November 30, 2018
Questions in the design of ANSWERIan A Rowe, Richard Parker
Gastroenterology|December 3, 2014
Liver biopsy for the selection of patients with nonalcoholic steatohepatitis for clinical trialsIan A Rowe, Richard Parker
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2021
The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply ExplainedIan A Rowe, Richard Parker
Nature Reviews. Gastroenterology & Hepatology|June 15, 2019
The diagnosis of nonalcoholic fatty liver disease should carry important prognostic informationIan A Rowe, Richard Parker
Pageof 10